俞永平药学院药学创新药物开发个人简介:学历背景： 浙江大学化学系，博士，2000   杭州大学化学系，硕士，1992  杭州大学化学系，学士，1987国外学习研究： 2000/2-2002/2  美国Torrey Pines分子研究所，博士后研究工作经历： 2004/6-至今 浙江大学药学院，现为药学院副院长、药物化学教授、博士生导师                                             2002/3-2004/6  美国Torrey Pines分子研究所，高级研究员 工作研究项目:20181.     国家重点研发计划政府间国际科技创新合作重点专项《中印尼生物技术联合实验室》（2017YFE0102200 2018.01-2020.12 项目负责人）20172.     国际合作项目-海外纵向《针对糖尿病药物开发的化合物库的构建-第二期》（KN20170874，2017.06-2022.12，项目负责人）3.     国际合作项目-海外纵向《针对镇痛药物开发的化合物库的构建-第二期》（KN20170873，2017.06-2022.12，项目负责人）4.     国际合作项目-海外纵向《针对阿尔兹海默尔症备选化合物的合成与筛选-第二期》（KN20170876，2017.06-2022.12，项目负责人）5.     国际合作项目-海外纵向《针对乳腺癌备选化合物的构建及筛选》（KN20170875 ，2017.06-2022.12，项目负责人）6.     国际合作项目-海外纵向《针对糖尿病药物开发的化合物库的构建》（KN20170034，2015.01-2018.12，项目负责人）7.     国际合作项目-海外纵向《针对镇痛药物开发的化合物库的构建》（KN20170033 ，2015.01-2018.12，项目负责人）8.     国际合作项目-海外纵向《针对阿尔兹海默尔症药物开发的化合物库的构建》（KN20170032，2015.01-2018.12，项目负责人）9.     国际合作项目-海外纵向《新型乳腺癌药物的研究》（KN20170035，2015.01-2018.12，项目负责人）10.    国家自然科学基金《基于多巴胺D2/D3受体激动活性及脑内祛铁双重功能分子的设计、合成及活性评价》（No. 81673291，2017-2020，项目负责人）11.    浙江大学-上海医药集团股份有限公司合作项目《抗耐药性EGFR抑制剂抗肿瘤新药候选化合物》，（H20142400，2013-2031，项目负责人）201512.    国家自然科学基金《基于骨架修饰的β-拟内吗啡肽设计、合成及活性评价》，（No. 81473074，2015.01-2018.12，项目负责人）201413.    浙江大学-杭州泽德医药科技有限公司合作项目《手性3-羟基吡啶衍生物及其合成》，（H20142924，2014-2031，项目负责人）14.    国家“十二五”重大新药创制专项《EGFR抑制剂（联合实验室）临床前及I期临床研究》（No. 2014ZX09304002-007 2014-2016，子课题负责人）；201315.    国家自然科学基金《基于EGFR/HER2/HDAC多靶点非可逆共价抑制剂的设计、合成及活性筛选》（No. 81273356，2013-2016，项目负责人）16.    国际合作项目《Development of new treatments for breast cancer》 (2013-2014 项目负责人)17.    国际合作项目《Synthesis and biological assessment of a new series of morphine derivatives》(2011-2015 项目负责人)18.    国际合作项目《The synthesis of tacrine-3-hydroxypyridin-4-one analogs as anti-Alzheimer》(2011-2015项目负责人)19.    国际合作项目《Synthesis of DDP IV inhibitors as anti-diabetes drugs》(2011-2015项目负责人)20.    浙江大学-宁波首南思达生物医药研究所合作项目《WST/PAP的合成》（No. H 20132606 2013-2014 项目负责人）201221.    国家“十一五”重大新药创制专项《孤儿药：地中海贫血袪铁药物CN128候选药物研究》 （No. 2012ZX09103101070，2012-2015，项目负责人）22.    浙江省科技厅《小分子药物研发关键技术创新团队》（N20120654， 2012-2015，项目负责人）201123.    国家自然科学基金《EGFR酪氨酸蛋白激酶抑制剂的设计、合成及活性评价》（No. 81072516，2011-2013，项目负责人）24.    浙江省自然科学基金《有机小分子诱导胚胎干细胞定向分化为类肝细胞及作用机理研究》（No. Z2110655 2011.01-2014.12项目负责人）201025.    国家“十一五”重大新药创制专项《上药集团研发体系产学研技术联盟建设-浙江大学》 （No. 2010ZX09401-404-006 ，2010-2012，子课题负责人）200926.    浙江大学-上海医药集团股份有限公司合作项目《酪氨酸激酶抑制剂抗肿瘤新药的研究和开发》（No. H20092607，2009-2012，项目负责人）27.    科技部“重大新药创制”之关键技术《类药性与靶向性化合物库及其制备关键技术研究》（No. 2009ZX09501-010，2009-2010，子课题负责人）28.    国家自然科学基金重大研究计划培育项目《基于诱导ES细胞定向分化的化合物库构建和信号转导分子事件发现》（No. 90813026；2009-2011，项目负责人）。29.    浙江大学-杭州盛友医药技术开发有限公司合作项目《利巴韦林前药SY301的合成研究》（No. H20091272，2009-2012，项目负责人）。200830.    浙江大学-宁波勤益化工合作项目《杂环化合物库的合成研究 》（No. H20081244 ；2008-2009，项目负责人）。31.    国家自然基金项目《蛋白激酶B抑制剂化合物库的合成及活性筛选》（No. 30772652；2008-2010，项目负责人）。200632.    浙江大学-浙江永太科技股份有限公司合作项目《医药原料药及中间体系列研究 》（No. H20062442；2006-2011，项目负责人）。33.    国家自然基金项目《可挥发固相载体用于快速合成环肽组合库及活性筛选研究》（No.20572098；2006-2008，项目负责人）。34.    浙江省自然科学基金重点项目《PKB抑制剂库分子多样性导向组合固相合成及活性筛选》（No.Z405037；2006 -2008，项目负责人）。200535.    浙江省科技厅国际合作项目《多肽及有机小分子在新型固相材料上合成的应用研究》（No.2005C34001 ；2005-2007，项目负责人）。 教学与课程:药物合成反应（本科生）药物化学实验（本科生）高等有机合成化学（博士研究生）药物化学专业英语（博士研究生）研究与成果:主要研究方向为靶向抗肿瘤和治疗地中海贫血祛铁创新药物研究，已发现针对非小细胞肺癌耐药的候选化合物SPH1188，并转让至上海医药集团股份有限公司进行临床前研究，2016年11月29日作为1.1类创新药获国家食品药品监督管理总局颁发“药物临床试验批件”，获准进入I-III期临床试验。发现具有自主知识产权的地中海贫血祛铁候选化合物CN128，有望解决我国在临床治疗地中海贫血方面药物匮乏的问题，2017年5月26日该候选化合物作为1.1类创新药获国家食品药品监督管理总局颁发“药物临床试验批件”，获准进入I-III期临床试验。发表论文:20181.   Donghong Zhao Haofan Luo Binhui Chen Wenteng Chen Guolin Zhang* and Yongping Yu* Palladium-Catalyzed H/D Exchange Reaction with 8-Aminoquinoline as the Directing Group: Access to ortho-Selective Deuterated Aromatic Acids and β-Selective Deuterated Aliphatic Acids. J. Org. Chem. 2018 accepted.2. En Chen Jiaan Shao Pai Tang Ke Shu Wenteng Chen* and Yongping Yu*，Catalyst-free three-component sequencing approach for efficient assembly of 1 3 oxazine N-fused imidazole-2-thiones. Green Chem. 2018 Accepted.3.   Xingyu Liu Zhuang Nie Jiaan Shao Wenteng Chen* Yongping Yu * A Multi-component synthesis of N-substituted 2-amino-3-cyano pyrroles via ring-opening of nitroepoxides. New J. Chem. 2018 42 2368-2371.20174. Jiaan Shao* Richard A. Houghten Colette T. Dooley Margret Cazares Jay P. McLaughlin Shainnel O. Eans Michelle L. Ganno Michelle R. Hoot Marc A. Giulianotti* and Yongping Yu* A one-pot multicomponent approach to a new series of morphine derivatives and their biological evaluation. Org. Biomol. Chem. 2017 15 7796-7801.5. Wenteng Chen Xingyu Liu En Chen Binhui Chen Jiaan Shao* Yongping Yu* KI-mediated radical multi-functionalization of vinyl azides: a one-pot and efficient approach to β-keto sulfones and α-halo-β-keto sulfones. Org. Chem. Front. 2017 4 1162-1166.6. Donghong Zhao Yue Zhu Shanshan Guo Wenteng Chen Guolin Zhang* Yongping Yu* A three-component one-pot synthesis of penta-substituted pyrroles via ring opening of α-nitroepoxides. Tetrahedron 2017 73 2872-2877.7. Pai Tang Can Zhang Binhui Chen Wenteng Chen* Yongping Yu* MnIII-catalyzed Phosphorylation of Vinyl Azides: The synthesis of ß-keto phosphine oxides. Tetrahedron Lett. 2017 58 2157-2161.8. Shanshan Guo Donghong Zhao Yue Zhu Yongping Yu Wenteng Chen* Guolin Zhang* One-pot three-component protocol for the synthesis of substituted 2-aminothiazoles. Synth. Commun.2017 47 1758-1764.  20169. Donghong Zhao Shanshan Guo Xiao Guo Guolin Zhang * Yongping Yu * Facile efficient synthesis of polysubstituted thiazoles via anitroepoxides and thioureas. Tetrahedron 2016 72 5285-528910. Yuqin Mei Zongfu Pan Wenteng Chen Minhua Xu Danyan Zhu Yongping Yu* Yijia Lou*. A flavonoid compound promotes neuronal differentiation of embryonic stem cells via PPAR-β modulating mitochondrial energy metabolism. Plos One. 2016 11 e015774711.Jiaan Shao En Chen Ke Shu Wenteng Chen* Guolin Zhang Yongping Yu * 6-Oxooxazolidine-quinazolines as noncovalent inhibitors with the potential to target mutant forms of EGFR. Bioorg. Med. Chem. 2016 24 3359-3370.12. Ke Shu Jiaan Shao Hong Li Binhui Chen Pai Tang Xingyu Liu Wenteng Chen * and Yongping Yu* Base-mediated synthesis of highly functionalized 2-aminonicotinonitriles from α-keto vinyl azides and α α-dicyanoalkenes. RSC Adv. 2016 6 49123-49126.201513. Binhui Chen Shanshan Guo Xiao Guo Guolin Zhang* Yongping Yu * Selective access to 4-substituted-2-aminothiazoles and 4-substituted-5-thiocyano-2-aminothiazoles from vinyl azides and potassium thiocyanate switched by palladium and iron catalysts. Org. Lett. 2015 17 4698.14.Jiaan Shao Xingyu Liu Ke Shu Pai Tang Jing Luo Wenteng Chen *and Yongping Yu* Tuning the Annulation Reactivity of Vinyl Azides and carbazates: A divergent synthesis of aza-pyrimidinones and imidazoles. Org. Lett. 2015 17 4502.15.Shanshan Guo Binhui Chen Xiao Guo Guolin Zhang* Yongping Yu* Mn(II)-catalyzed synthesis of benzofindole-49-diones via vinyl azides and 2- hydroxynaphthoquinone. Tetrahedron 2015 71 9371.16.Wei Huang Shen Liu Binhui Chen Xiao Guo and Yongping Yu* Synthesis of polysubstituted 4-aminopyrazoles and 4-hydroxypyrazoles from vinyl azides and hydrazines. RSC Adv. 2015 5 32740.17.Jing Luo Wenteng Chen Jiaan Shao Xingyu Liu Ke Shu Pai Tang and Yongping Yu*Synthesis of poly-functionalized imidazoles via vinyl azides annulation. RSC Adv. 2015 5 55808.18. Xiao Guo Jiaan Shao HuanLiu Binhui Chen Wenteng Chen Yongping Yu* Highly efficient and eco-friendly protocol to functionalized imidazoles via ring-opening of α-nitro epoxides. RSC Adv. 2015 5 51559.19.Xiao Guo Wenteng Chen Binhui Chen Wei Huang Weixing Qi Guolin Zhang* and Yongping Yu* One-pot three-component strategy for functionalized 2‑aminoimidazoles via ring opening of α-nitro epoxides. Org. Lett. 2015 17 1157.20.Hangcheng Ni Guolin Zhang* and Yongping Yu* Vinyl azides as versatile synthons for the synthesis of nitrogen-containing heterocycles. Curr. Org. Chem. 2015 19 2750.21.Guolin Zhang* Binhui Chen Xiao Guo Shanshan Guo and Yongping Yu* Iron (II)-promoted synthesis of 2-aminothiazoles via C-N bond formation from vinyl azides and potassium thiocyanate. Adv. Synth. Catal. 2015 357 1065.22.Miao Hu Marc A. Giulianotti Jay P. McLaughlin Jiaan Shao Ginamarie Debevec Laura E. Maida Phaedra Geer Margaret Cazares Jaime Misler Ling Li Colette Dooley Michelle L. Ganno Shainnel O. Eans Elisa Mizrachi Radleigh G. Santos Austin B. Yongye Richard A. Houghten * Yongping Yu* Synthesis and biological evaluations of novel endomorphin analogues containing α-hydroxy-β-phenylalanine (AHPBA) displaying mixed μ/δ opioid receptor agonist and d opioid receptor antagonist activities. Eur. J. Med. Chem. 2015 92 270.201423.Guangxin Xia Wenteng Chen Jing Zhang Jiaan Shao Yong Zhang Wei Huang Leduo Zhang Weixing Qi Xing Sun Bojun Li Zhixiong Xiang Chen Ma Jia Xu Hailin Deng Yufeng Li Ping Li Hong Miao Jiansheng Han Yanjun Liu Jingkang Shen* and Yongping Yu* A chemical tuned strategy to develop novel irreversible EGFR-TK inhibitors with improved safety and pharmacokinetic profiles. J. Med. Chem. 2014 57 9889.24.Shen Liu Wenteng Chen Jing Luo and Yongping Yu* 3+3 annulation of allylic phosphoryl-stabilized carbanions/phosphorus ylides and vinyl azides: a practice strategy for synthesis of polyfunctionalized anilines. Chem. Commun. 2014 50 8539.25.Binhui Chen Hangcheng Ni Xiao Guo Guolin Zhang* and Yongping Yu* Facile preparation of 3 5-disubstituted-4-aminothiophene-2-carbaldehyde from a novel unexpected domino reaction of vinyl azides and 1 4-dithiane-2 5-diol. RSC Adv. 2014 4 44462.26.Bo Tian Tao Jiang Zhanying Shao Zanjing Zhai Haowei Li Qiming Fan Xuqiang Liu Zhengxiao Ouyang Tingting Tang Qing Jiang Minghao Zheng Kerong Dai An Qi* Yongping Yu* Zhenan Zhu* The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis. Biomaterials 2014 35 8937-8950.27.Tao Jiang An Qin ZhanYing Shao Bo Tian Zanjing Zhai Haowei Li Zhenan Zhu Kerong Dai Minghao Zheng Yongping Yu * Qing Jiang OA10 Is a Novel p38alpha Mitogen-Activated Protein Kinase Inhibitor That Suppresses Osteoclast Differentiation and Bone Resorption. J. Cell. Biochem. 2014 115 959.28.Bo Tian An Qin Zhanying Shao Tao Jiang Zanjing Zhai Haowei Li Tingting Tang Qing Jiang Kerong. Dai Minghao Zheng Yongping Yu * Zhenan Zhu OA-4 Inhibits Osteoclast Formation and Bone Resorption via Suppressing RANKL Induced P38 Signaling Pathway. Curr. Med. Chem. 2014 21 641.29.Shen Liu  Jiaan Shao  Xiao Guo  Jing Luo  Menghao Zhao  Guolin Zhang  Yongping Yu * Facile efficient synthesis of polyfunctionalized 2-aminoimidazoles via vinyl azides and cyanamide. Tetrahedron 2014 70 1418.30.Jingfeng Ouyang Wei Huang Wanwan Yu Wei Xiong Ramanjaneya V.R. Mula Hongbin Zou Yongping Yu * Generation of insulin-producing cells from rat mesenchymal stem cells using an aminopyrrole derivative XW4.4. Chem-Biol Interact 2014 208 1.201331. Jinhua Wu Yaohong Zhang Laura E. Maida Radleigh G. Santos Gregory S. Welmaker Travis M. LaVoi Adel Nefzi Yongping Yu Richard A. Houghten Lawrence Toll* and Marc A. Giulianotti*. Scaffold ranking and positional scanning utilized in the discovery of nAChR-selective compounds suitable for optimization studies. J. Med. Chem. 2013 56 10103.32. Yanli Cui Zhaodong Cheng Jianwei Mao Yongping Yu Regioselective 6-detrimethylsilylation of per-O-TMS-protected carbohydrates in the presence of ammonium acetate. Tetrahedron Lett. 2013 54 3831.33.Jianwei Wu Wenteng Chen Guangxin Xia Jing Zhang Jiaan Shao Biqin Tan Chunchun Zhang Wanwan Yu Qinjie Weng Haiyan Liu Miao Hu Hailin Deng Yu Hao Jingkang Shen* and Yongping Yu* Design synthesis and biological evaluation of novel conformationally constrained inhibitors targeting EGFR. ACS Med. Chem. Lett. 2013 4 974.34.Miao Hu Wei Huang Marc A. Giulianotti Richard A. Houghten and Yongping Yu* Parallel Synthesis of 1 6-disubstituted-1 2 4-triazin-3-ones on solid-phase. ACS Comb. Sci. 2013 15 335.35.Jun Chen Wenteng Chen Yongping Yu * and Guolin Zhang * One-pot synthesis of disubstituted imidazole derivatives from a-azido ketones catalyzed by potassium ethylxanthate. Tetrahedron Lett. 2013 54 1572.36.Jun Chen Hangcheng Ni Wenteng Chen Guolin Zhang * and Yongping Yu * A new strategy for facile synthesis of tetrasubstituted pyridine derivatives. Tetrahedron 2013 69 8069.37.Guolin Zhang* Hangcheng Ni Wenteng Chen Jiaan Shao Huan Liu Binhui Chen and Yongping Yu* One-pot three-component approach to the synthesis of polyfunctional pyrazoles. Org. Lett. 2013 15 5967.38.Li Wang Wenteng Chen Zhanying Shao Shen Liu and Yongping Yu* Selective halogenation of arylurea derivatives by Pd-catalyzed C-H activation. Curr. Org. Chem. 2013 17 3092.39. Wenteng Chen Jiaan Shao Miao Hu Wanwan Yu Marc A. Giulianotti Richard A. Houghten* and Yongping Yu* A traceless approach to amide and peptide construction from thioacids and dithiocarbamate-terminal amines Chem.Sci. 2013 4 970.40.Ginamarie Debevec Wenteng Chen Yongping Yu Richard A. Houghten  Marc A. Giulianotti * Libraries from libraries: a series of sulfonamide linked heterocycles derived from the same scaffold. Tetrahedron Letters 2013 54 4296.41.Wanwan Yu Wenteng Chen Shen Liu Jiaan Shao Zhanying Shao Yongping Yu* Facile eco-friendly catalyst-free synthesis of polyfunctionalized 2-aminopyrroles. Tetrahedron 2013 69 1953.42. Yaohong Zhang Shen Liu Wanwan Yu Miao Hu Guolin Zhang Yongping Yu* Palladium-catalyzed synthesis of 3-alkenyl indoles from 2-azido-3-arylacrylates and terminal alkenes at room temperature. Tetrahedron 2013 69 2070.201243. Marc A. Giulianotti Gina Debevec RG Santos Laura E. Maida Wenteng Chen Lili Ou Yongping Yu CT Dooley Richard A. Houghten A novel method for the determination of isokinetic ratios and its application in the synthesis of two new positional scanning libraries. ACS Comb. Sci. 2012 14 503.44. Jiaying Wu Zongfu Pan Zhiqiang Wang Wenjie Zhu Yuanyuan Shen Rong Cui Jiazhen Lin Hao Yu Qiongque Wang Jianchang Qian Yongping Yu Danyan Zhu Yijia Lou Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway. Neuropharmacology 2012 63 349.45.Xingguang Liang Yuqin Mei Xin Huang Guofang Shen Danyan Zhu Yongping Yu Jianan Wang* Yijia Lou.* Junctophilin 2 knockdown interfere with mitochondrium status in ESC-CMs and cardiogenesis of ES cells. J Cell Biochem. 2012 113 2884.46. Jiaying Wu Zongfu Pan Zhiqiang Wang Wenjie Zhu Yuanyuan Shen Rong Cui Jiazhen Lin Hao Yu Qiongque Wang Jianchang Qian Yongping Yu Danyan Zhu * Yijia Lou * Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway. Neuropharmacology 2012 63 349.47. Yanli Cui* Minghan Xu Jianwei Maob Jingfeng Ouyang Rongzhen Xu Yongping Yu Synthesis of berbamine acetyl glycosides and evaluation of antitumor activity. Eur. J. Med. Chem. 2012 54 867.48.Guofang Shen Ying Hu Jianwei Wu Ke Jin Danyan Zhu Yandong Zhang Yongping Yu* and Yijia Lou*. A 2 6-disubstituted 4-anilinoquinazoline derivative facilitates cardiomyogenesis of embryonic stem cells. ChemMedChem 2012 7 733.49.Jiaan Shao Wanwan Yu Zhanying Shao Yongping Yu* A “one-pot” multicomponent approach to polysubstituted 4-aminopyridines Chem. Commun. 2012 48 2785.50. Zhanying Shao Qinghai Pan Jun Chen Yongping Yu* Guolin Zhang* Synthesis of polysubstituted 5-aminopyrimidine-2(1H)-thiones from vinyl azides and thiourea Tetrahedron 2012 68 6565.51.Fangli Qiu Jianwei Wu Yaohong Zhang Miao Hu Yongping Yu* One-pot cascade approach to 13´-bipyrrole derivatives from trisubstituted olefins with tosylmethyl-isocyanide (TosMIC) Tetrahedron Lett. 2012 53 446.52.Jingfeng Ouyang Jiaan Shao Hongbin Zou Yijia Lou Yongping Yu* Hepatic differentiation of rat mesenchymal stem cells by a small molecule ChemMedChem 2012 7 1447.53. Wenteng Chen Jiaan Shao Zhi Li Giulianotti MA Yongping Yu* Synthesis of 234- trisubstituted pyrroles via a facile reaction of vinyl azides and tosylmethyl isocyanide Can. J. Chem. 2012 90 214.54. Fangli Qiu Jianwei Wu Yaohong Zhang Miao Hu Feng Yu Guolin Zhang Yongping Yu* A novel synthesis of multisubstituted pyrroles via trisubstiuted olefins and TosMIC derivatives Lett. Org. Chem. 2012 9 305.55. Joshua J. Ziarek Yan Liu Emmanuel Smith Guolin Zhang Francis C. Peterson Jun Chen Yongping Yu Yu Chen Brian F. Volkman and Rongshi Li.* Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction. Curr Top Med Chem. 2012 12 2727.201156. Li Wang Shen Liu Zhi Li Yongping Yu* Palladium-catalyzed direct olefination of urea derivatives with n-butyl acrylate by C-H bond activation under mild reaction conditions Org. Lett 2011 13 6137.57.Miao Hu Jianwei Wu Yaohong Zhang Fangli Qiu Yongping Yu* Synthesis of polysubstituted 5-aminopyrimidines from α-azidovinyl ketones and amidines Tetrahedron 2011 67 2676.58.Lili Ou Jiaan Shao Guolin Zhang* Yongping Yu*; Metal-free carbon–nitrogen bond-forming coupling reaction between arylboronic acids and organic azides Tetrahedron Lett. 2011 52 1430.59.Wenteng Chen Zhi Li Lili Ou Giulianott MA Houghten RA Yongping Yu* Solid-phase synthesis of skeletally diverse benzofused sultams via palladium-catalyzed cyclization Tetrahedron Lett. 2011 52 1456.60. Hongbin Zou Liang Zhang Jingfeng Ouyang Giulianott MA Yongping Yu* Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents Eur. J. Med. Chem. 2011 46 5970.61. Hongbin Zou Huajian Zhu Jiaan Shao Jianwei Wu Wenteng Chen Marc A. Giulianotti Yongping Yu* A facile approach to polysubstituted pyrazoles from hydrazonyl chlorides and vinyl azides Tetrahedron 2011 674887.62.Hongbin Zou Liang Zhang Leixiang Yang Liuqing Yang Yu Zhao Yongping Yu Joachim Stöckigt* Nat. Prod. Res. 2011 25 203-221.63.Huajian Zhu Joachim Stöckigt Yongping Yu and Hongbin Zou*“One-Pot” Multicomponent Approach to Indolizines and Pyrido12-aindoles Org. Lett. 2011 13 2792–2794.64.Lili Ou Zhanying Shao Wenteng Chen Giulianotti MA Houghten RA Yongping Yu* Solid-Phase Synthesis of 2356-Tetrahydro-1H-imidazo12-abenzod-13 diazepines via Pd(OAc)2/Cu(OAc)2-Cocatalyzed Cyclization Synlett 2011 15 2259-226165.Jue Zhou* Fan Qu Yongping Yu Chemical and Ecological Evaluation of a Genuine Chinese Medicine: Atractylodes Macrocephala Koidz Afr. J. Tradit. Complem. 2011 8 405-41166.Lili Ou Shuang Han Wenbo Ding Ping Jia Bo Yang Medina-Franco JL Giulianotti MA Jian-zhong Chen Yongping Yu* Parallel synthesis of novel antitumor agents: 123-triazoles bearing biologically active sulfonamide moiety and their 3D-QSAR Mol Divers 2011 15 927-94667.Lili Ou Shuang Han Wenbo Ding Zhe Chen Ziqi Ye Hongyu Yang Guolin Zhang Yijia Lou Jian-zhong Chen Yongping Yu* Design synthesis and 3D-QSAR study of cytotoxic flavonoid derivatives Mol Divers. 2011 15 665-675.68.Zhe Chen Xin Huang Hongyu Yang Wenbo Ding Lingyan Gao Ziqi Ye Yandong Zhang Yongping Yu∗ Yijia Lou∗ Anti-tumor effects of B-2 a novel 23-disubstituted 8-arylamino-3H-imidazo45-gquinazoline derivative on the human lung adenocarcinoma A549 cell line in vitro and in vivo. Chemico-Biological Interactions 2011 189 90-99.201069. Wenteng Chen Miao Hu Jianwei Wu Hongbin Zou Yongping Yu*. Domino Approach for the Synthesis of Pyrrolo12-pyrazine from Vinyl Azides. Org. Lett. 2010 12 3863–3865.70.Hongbin Zou Hao Wu Xiangnan Zhang Yu Zhao Joachim Stöckigt Yijia Lou Yongping Yu*. Synthesis biological evaluation and structure–activity relationship study of novel cytotoxic aza-caffeic acid derivatives. Bioorg. Med. Chem. 2010 18 6351–6359.71.Hongbin Zou Huajian Zhu Liang Zhang Liuqing Yang Yongping Yu* and Joachim Stöckigt. *A Facile Chemoenzymatic Approach: One-Step Syntheses of Monoterpenoid Indole Alkaloids. Chem.–an Asian J. 2010 5 2400–2404.72. Ting Ma Wenteng Chen Guolin Zhang and Yongping Yu*.Synthesis and Antitumor Evaluation of a Novel Class of 4-Substituted-1 4-Dihydroisoquinolin-3-ones J. Comb. Chem. 2010 12 488–490.73.Jianwei Wu; Wenteng Chen; Miao Hu; Hongbin Zou; Yongping Yu*. Synthesis of polysubstituted 5-aminooxazoles from α-diazocarbonyl esters and α-isocyanoacetamides. Org. Lett. 2010 12 616–618.74.Ziqi Ye Zhe Chen Wenteng Chen Jinwen Xie Hongyu Yang Yijia Lou* Yongping Yu*. XJW20 a novel oxoindole derivative induces G2/M arrest and apoptosis selectively in K562 leukemia cell line. Chem.-Biol. Interact. 2010 183 133–141.75.Zhang Hu Wei Ye Hongbin Zou Yongping Yu*. 2 2’-Biimidazole as an Efficient Ligand for Copper (I)-Catalyzed C-N Coupling Reactions. Synth. Commun. 2010 40(2) 222-228.76.Chao Yao; Yandong Zhang; Guolin Zhang; Wenteng Chen; Richard A Houghten. Yongping Yu*; Traceless Approach for the Synthesis of 3 5-Disubstituted Thiohydantoins on Functionalized Ionic-Liquid Support. Synth. Commun. 2010 40 717–724.77.Yanli Cui; Caixia Wang; Jianwei Mao; Yongping Yu*. A facile and practical approach to randomly methylated β-cyclodextrin. J. Chem. Tech. Biotech. 2010 85 248–251.200978.Jinwen Xie Ting Ma Ying Gu Xuzhao Zhang Xi Qiu Lei Zhang Rongzhen Xu Yongping Yu*. Berbamine derivatives: A novel class of compounds for anti-leukemia activity. Eur. J. Med. Chem. 2009 44 3293–3298.79.Yandong Zhang Zhe Chen Yijia Lou Yongping Yu*. 2 3-Disubstituted 8-arylamino-3H-imidazo 4 5-gquinazolines: a novel class of antitumor agents. Eur. J. Med. Chem. 2009 44 448–452.80. Zhang Hu Ting Ma Zhe Chen Ziqi Ye Guolin Zhang Yijia Lou Yongping Yu*. Solid-phase synthesis and antitumor evaluation of 2 4-diamino-6-aryl-1 3 5-triazines. J. Comb. Chem. 2009 11 267–273.81.Yangmei Li Yongping Yu* Marc Giulianotti Richard A. Houghten. One-pot high-throughput synthesis of β-turn cyclic peptidomimetics via "volatilizable" supports. J. Org. Chem. 2009 74 2183–2185.82.Zhiqiang Wang Huanhuan Wang Jiaying Wu Danyan Zhu Xiangnan Zhang Lili Ou Yongping Yu Yijia.Lou*. Enhanced co-expression of beta-tubulin III and choline acetyltransferase in neurons from mouse embryonic stem cells promoted by icaritin in an estrogen receptor-independent manner. Chem.-Bio. Interact.. 2009 179 375–385.83.Yangmei Li Austin Yongye Marc Giulianotti Karina Martinez-Mayorga Yongping Yu Richard A. Houghten*. Synthesis of cyclic peptides through direct aminolysis of peptide thioesters catalyzed by imidazole in aqueous organic solutions. J. Comb. Chem. 2009 11 1066–1072.84.Austin B. Yongye Yangmei Li Marc A. Giulianotti Yongping Yu Richard A. Houghten* Karina Martinez-Mayorga. Modeling of peptides containing D-amino acids: implications on cyclization. J. Comp.-Aided Mol. Des. 2009 23 677–689.85.Jose L. Medina-Franco* Marc A. Giulianotti Yongping Yu Liangliang Shen Libo Yao Narender Singh. Discovery of a novel protein kinase B inhibitor by structure-based virtual screening. Bioorg. Med. Chem. Lett. 2009 19 4634–4638.86. Ping Jia Xuling Wu Yongping Yu Guolin Zhang*. An efficient one-pot synthesis of 5 9-cyclo-1 11-oxido-pregn-16-ene-3 20-dione from 9-bromo-11-hydroxypregna-1 4 16- triene-3 20-dione by two annulation reactions. Steroids 2009 74 229–232.200887. Yandong Zhang Chao Yao Richard A. Houghten Yongping Yu*. Solid-phase Synthesis of 4 8-Disubstituted-8 9-dihydropyrazino 2 3-g quinazolin-7(6H)-ones. Biopolymer (Peptide Science) 2008 90 439–443.88.Yangmei Li Yongping Yu Marc Giulianotti Richard A. Houghten*. High Throughput Synthesis of Peptide a-Thioesters Through the Use of “Volatilizable” Support. J. Comb. Chem. 2008 10 613–616.89.Yangmei Li Yongping Yu* Marc Giulianotti Richard A. Houghten. High-throughput parallel synthesis of 3 4-disubstituted 1-(x-hydroxyalkyl) imidazolin-2-ones on ‘volatilizable’ supports. Tetrahedron Lett. 2008 49 3632–3633.90.Yanbo Wo; Danyan Zhu; Yongping Yu; Yijia Lou*. Involvement of NF-κB and AP-1 activation in icariin promoted cardiac differentiation of mouse embryonic stem cells. Eur. J. Pharm. 2008 586 59–66.200791.Jinwen Xie; Jing Sun; Guolin Zhang; Richard A. Houghten; Yongping Yu*. A traceless approach for the solid-phase parallel synthesis of trisubstituted oxindoles. J. Comb. Chem. 2007 9 566–568.92. Yandong Zhang; Chuanlian Xu; Richard A Houghten.; Yongping Yu*. Scaffold Approach for Solid-Phase Synthesis of 2 3-Disubstituted 8-Arylamino-3H-imidazo 4 5-gquinazolines.    J. Comb. Chem. 2007 9 9–11.93.Yandong Zhang; Qiaosheng Zhou; Richard A Houghten.; Yongping Yu*. Solid-phase synthesis of 3-alkyl-8-arylamino-1H-imidazo 4 5-g quinazolin-2(3H)-thiones and 3-alkyl-8-arylamino-1H- imidazo 4 5-g quinazolin-2(3H)-ones. Tetrahedron Lett. 2007 48 7042–7045.Before 200794.Richard A. Houghten* Yongping Yu*. “Volatilizable” Supports For High-throughput Organic Synthesis. J. Am. Chem. Soc. 2005 127 8582–8583.95.Yongping Yu John M. Ostresh Richard A. Houghten. “A Traceless Approach for the Solid Phase Synthesis of Substituted 6-Amino-1 3 5-triazine-2 4-diones”. J. Comb. Chem. 2004 6 83. 96.G. Zhong Yongping Yu. “Enantioselective Synthesis of Allylic Alcohols by the Sequential Aminoxylation-Olefination Reactions of Aldehydes under Ambient Conditions.” Org. Lett. 2004 6 1637 97.A. Nefzi John M. Ostresh. Yongping Yu Richard A. Houghten. Combinatorial Chemistry: Libraries from Libraries the Art of the Diversity-Oriented Transformation of Resin-Bound Peptides and Chiral Polyamides to Low Molecular Weight Acyclic and Heterocyclic Compounds. J.Org. Chem. 2004 69 3603.98.Yongping Yu John M. Ostresh Richard A. Houghten. “The Combined Solid / Solution-Phase Synthesis of Nitrosamines: The Evolution of the ‘Libraries from Libraries’ Concept.”  J. Org. Chem. 2003 68 183.99.Yongping Yu John M. Ostresh Richard A. Houghten. “Solid Phase Synthesis of Indolines via Palladium-Catalyzed Cyclization.” Tetrahedron Lett. 2003 44 2569.100.Yongping Yu John M. Ostresh Richard A. Houghten. “Solid Phase Synthesis of 3-amino-124-triazoles.” Tetrahedron Lett. 2003 44 7841.101.Yongping Yu John M. Ostresh Richard A. Houghten. “The Combined Solid and Solution-Phase Synthesis of Small Molecular Libraries: The Evolution of “Libraries from Libraries” Concept.” In Peptide Revolution: Genomics Proteomics & Therapeutics Proceedings of the 18th American Peptide Symposium. American Peptide Society 2003.102.Yongping Yu John M. Ostresh Richard A. Houghten. Efficient Solid-Phase Synthesis of 1 3 5-Trisubstituted-246-Trione Derivatives. J.Comb.Chem.2002 4 484.103.Yongping Yu John M. Ostresh Richard A. Houghten. A Traceless Approach for the Parallel Solid Phase Synthesis of 2-(Arylamino)quinazolinones. J.Org.Chem 2002 67 5831.104.Yongping Yu John M. Ostresh Richard A. Houghten. Solid-Phase Synthesis of 1 5-Disubstituted-2-Arylimidazolones. J. Org. Chem. 2002 67 3138.105. Yongping Yu John M. Ostresh Richard A. Houghten. Solid-Phase Parallel Synthesis of 2-aminoimidazolidin-4-ones. Tetrahedron 2002 58 3349.106. Yongping Yu John M. Ostresh Richard A. Houghten. Solid-Phase Synthesis of 2 3 5- Trisubstituted 4H-Imidazolones. J.Comb. Chem. 2001 3 521.107.Yongping Yu John M. Ostresh Richard A. Houghten. Solid-Phase Synthesis of 1 7-Disubstituted-1 3 5-triazepane-24-diones. Org. Lett. 2001 3 2797.108. Yongping Yu John M. Ostresh Richard A. Houghten. Solid-Phase Synthesis of 3 5 7- 1H-imidazo15-αimidazol-2(3H)-ones. Tetrahedron Lett. 2001 42 623.出版著作:1.       《药物设计学》、普通高等教育“十一五”国家级规划教材、2015.08、高等教育出版社、2.8万字/25万字。2.       《药物设计学》、普通高等教育“十一五”国家级规划教材、2008.01、高等教育出版社、3.5万字/25万字。3.       《药学概论》、全国高等学校药学类规划教材、2007.04、高等教育出版社、4.3万字/44万字。4.       《Solid-Phase Organic Synthesis》Wiley出版社，第九章5.       Yongping Yu Nefzi A. John M. Ostresh Richard A. Houghten. Parallel solid phase synthesis mixture based combinatorial libraries & libraries from libraries: The versatility of chiral polyamines. In: Innovation and Perspectives in Solid Phase Synthesis & Combinatorial Libraries 2004 (Epton R. Ed.) Mayflower Worldwide Kingswinford UK 2004 pp. 1-4.专利成果: 2017 舒可，邵加安，唐湃，陈斌辉，陈文腾，俞永平，456-多官能团化-2-氨基烟腈衍生物及其制备方法。授权日：2017.12.26，专利号：201510647954.6。 陈文腾、刘星雨、陈斌辉、邵加安、俞永平，一种β-芳酮基取代的砜类化合物的制备方法。授权日：2017.10.20，专利号：ZL201610210490.7。 陈文腾、唐湃、舒可、陈斌辉、邵加安、俞永平，一种β-酮基取代的磷酸酯类化合物的制备方法。授权日：2017.10.20，专利号：ZL201610209366.9。郭晓，邵加安，俞永平。一种245-三取代的咪唑类化合物的制备方法。授权日：2017.10.20，中国，专利号：ZL201510162630.3邵加安、刘星雨、舒可、陈斌辉、陈文腾、俞永平，2，4，5-多取代咪唑类化合物及制备方法，授权日：2017.09.15，专利号：ZL201510371663.9 郭晓、刘燊、陈其算、俞永平，一种多取代134-噻二嗪类化合物及制备方法。授权日：2017.04.12，专利号：ZL201510162591.7黄卫、刘燊、陈斌辉、郭晓、俞永平，一种多取代4-羟基吡唑类衍生物的制备方法。授权日：2017.01.18，专利号：ZL201410540869.5章国林、陈斌辉、俞永平，4-取代-5-硫氰基-2-氨基噻唑化合物的制备方法。授权日：2017.01.04，专利号：ZL 201510378208.1章国林、陈斌辉、郭闪闪、俞永平，4-取代-2-氨基噻唑化合物的制备方法。授权日：2017.01.04，专利号：ZL 201510377544.42016 Robert Hider Zudong Liu Yongping Yu Zhi Li. Chiral 3-hydroxypyrid-4-one derivative and synthesis and use thereof. EP 2692724B1.章国林，倪航程，俞永平。吡啶-23-二羧酸二乙酯的制备方法。授权日：2016.08.24，中国，专利号：ZL 201410649985.0陈文腾，罗婧，邵加安，刘星雨，俞永平。一种多取代咪唑类衍生物的制备方法。授权日：2016.08.24，中国，专利号：ZL201410530581.X夏广新，俞永平，陈文腾，张永，沈竞康。喹啉及喹唑啉衍生物、制备方法、中间体、组合物及应用。授权日：2016.08.17，中国，专利号：ZL201410036231.8。郭晓，陈文腾，齐维兴，陈斌辉，黄卫，俞永平。一种145-三取代-2-氨基咪唑类化合物的制备方法。授权日：2016.07.13，中国，专利号：ZL201410576223.2俞永平、罗婧、陈文腾、刘星雨、舒可，含异羟肟酸片段的2-芳胺基嘧啶类衍生物、制备方法及应用。授权日：2018.05.08，中国，专利号：ZL201610034632.9。陈文腾、邵加安、刘星雨、罗婧、俞永平。含噁唑烷酮环侧链的喹唑啉衍生物及制备和应用。授权日：2016.05.18，专利号：ZL201310528258.4章国林、赵冬红、郭闪闪、俞永平，45-二取代-2-取代氨基噻唑化合物的制备方法。公开日：2016.04.27，申请号：CN201610072110.8。章国林、陈斌辉、俞永平，2-氨基噻唑-4-甲酸乙酯的制备方法。授权日：2016.04.27，专利号：ZL201410324135.3。章国林、郭闪闪、俞永平，2-氰基-4’-甲基联苯的制备方法。授权日：2017.06.30，专利号：ZL201510776200.0。俞永平，邵加安，吴政杰，一种左旋氧氟沙星及氧氟沙星的合成方法。授权日：2016.03.30，专利号：ZL 201310649880.0。章国林、陈斌辉、倪航程、俞永平，45-二取代-2-氨基噻唑化合物及其制备方法。授权日：2016.02.24，专利号：ZL201410321285.9。2015章国林，陈斌辉，倪航程，俞永平。35-二取代-4-氨基噻吩-2-甲醛化合物及其制备方法。授权日：2015.11.18，中国，专利号：ZL 201410196456.X吴建伟，陈文腾，何俏军，俞玩玩，胡苗，俞永平。喹唑啉衍生物及其制备方法和用途。授权日：2015.11.04，中国，专利号：ZL201210411352.7章国林，郭闪闪，赵冬红，俞永平。23-二取代-1H-苯并f吲哚-49-二酮化合物及其制备法。授权日：2017.06.13，中国，专利号：ZL201510200354.5夏广新，沈竞康，俞永平，陈文腾，张春春，郝宇，张晶，李伯俊，刘学军。喹唑啉衍生物，其制备方法、中间体、组合物及其应用。授权日：2015.07.29，中国，专利号：ZL201210279708.6。章国林，倪航程，陈斌辉，俞永平。345-三取代吡唑类化合物及其制备方法。授权日：2015.03.25，中国，专利号：ZL 201310227193.X。章国林，陈俊，倪航程，俞永平。36-二氯-2-羟基苯甲酸的制备方法。授权日：2015.03.25，中国，专利号：ZL 201210576202.1。2014章国林，陈俊，倪航程，俞永平。36-二氯-2-羟基苯甲酸的合成方法。授权日：2014.11.26，中国，专利号：ZL201210560750.5章国林，陈俊，陈文腾，俞永平。取代2-羰基咪唑类化合物的制备方法。授权日：2014.11.26，中国，专利号：ZL201210343887.5。章国林、邵展颖、陈俊、潘钦孩、俞永平，5-氨基嘧啶硫酮类化合物及其制备方法，授权日：2014.04.16，专利号: ZL 201110434099.2 邹宏斌、祝华建、约阿施•史托克希特、俞永平，一种类异胡豆苷生物碱及制备方法和用途，授权日：2014.02.19，专利号: CN201110456721.X邵加安、陈文腾、夏广新、俞玩玩、沈竞康、俞永平、张永。含吖丙啶环侧链的喹唑啉衍生物及制备和应用。公开日：2014.02.12，公开号：CN103570692A2013俞永平，俞玩玩，吴政杰。一种左旋氧氟沙星及氧氟沙星的一步合成方法。授权日：2013.09.04，中国，专利号：201210200823.X  欧丽丽、邵加安、章国林、俞永平，一种芳香仲胺的制备方法，授权日：2013.05.01，专利号: CN 201010218409.22012崔艳丽、王彩霞、俞永平、毛建卫，提取农林副产品中的神经酰胺两性脂质的方法，授权日：2012.11.28，专利号: ZL200910099483.4俞永平、罗伯特海德、李智、刘祖东，手性3-羟基吡啶-4-酮类衍生物及其合成和用途，授权日：2012.11.21，中国，专利号：ZL201110080525.7游金宗、俞永平、蒋善会、任海华，一种拉米夫定的制备方法，授权日：2012.11.21，中国，专利号：ZL201110052195.0邹宏斌、祝华建、约阿施•史托克希特、俞永平，阿吗碱类衍生物及制备和用途，授权日：2012.08.22，专利号：CN201010143719.2邹宏斌、祝华建、约阿施•史托克希特、俞永平，异胡豆苷内酰胺类衍生物及制备和用途，授权日：2012.07.25，专利号: CN201010143703.1邹宏斌、祝华建、约阿施•史托克希特、俞永平，Nacyline类衍生物及制备和用途，授权日：2012.05.09，专利号：CN201010143716.92011崔艳丽、毛建卫、俞永平，一种对富含硅的生物质废弃物综合利用的方法，授权日：2011.12.14，专利号: CN201010116250.3楼宜嘉、朱丹雁、王志强、王欢欢、吴佳莹、梅宇钦、许敏华、俞永平、欧丽丽，异补骨脂甲素诱导干细胞定向分化为神经细胞的用途，授权日：2011.11.30，专利号: CN200810061401.2章国林、邹宏斌、熊伟、俞永平，氨基吡咯类化合物及其制备方法，授权日：2011.11.23，专利号：CN201010157903.2胡 章、叶 苇、吴旭伶、章国林、俞永平，246-三取代-135-三嗪类衍生物库及制备方法，授权日：2011.04.13，专利号：ZL200810063051.3徐荣臻、于晓方、俞永平、谢进文、古 莹、张旭照、干小仙，一类小檗胺衍生物及其盐的应用，授权日：2011.02.09，专利号: CN200810060382.12010章砚东、陈 哲、楼宜嘉、俞永平，8-芳胺基-3H-咪唑45-g喹唑啉类衍生物的用途，授权日：2010.11.24，专利号：CN200810063051.3楼宜嘉、俞永平、胡 颖、朱丹雁、章砚东、梁星光、欧丽丽，喹唑啉咪唑化合物的用途，授权日：2010.09.08，专利号：CN200810060884.4胡 章、程佩玲、徐少军、俞永平，紫杉醇及多烯紫杉醇的合成方法，授权日：2010.08.18，专利号：CN200710066940.0邹宏斌、张丽娟、约阿施•史托克希特、赵 昱、张勇民、俞永平、曾 苏，取代桂皮酰哌嗪衍生物及其制备方法和用途，授权日：2010.07.27，专利号: CN200710156909.6李扬眉、贾平，孙静，俞永平，用可挥发苄巯基硅胶合成多肽硫酯库的固相合成方法，授权日：2010.06.23，专利号：CN200710067153.8周 珏、曲 凡、俞永平，一种用于治疗慢性盆腔炎的中药组合物及应用，授权日：2010.06.23，专利号：CN200710156908.1邹宏斌、吴 昊、约阿施•史托克希特、赵 昱、张勇民、俞永平、曾 苏，4＇-取代苄氧基-苯基丁二烯类衍生物及制备和用途，授权日：2010.03.31，专利号：CN200710156910.92009章砚东，许传莲，俞永平。8-芳胺基-3H-咪唑45-g喹唑啉类衍生物及其固相合成方法。授权日：2009.08.25，专利号：CN 200610053895.0。谢进文、俞永平、徐荣臻、楼宜嘉、马 婷，一类吲哚啉-2-酮衍生物及其用途，公开日：2009.05.06，申请号: CN200810163167.42008胡 章、陈 哲、叶子奇、羊红玉、楼宜嘉、俞永平，2-烃基取代46-二氨基-135-三嗪类衍生物的用途，公开日：2008.11.19，申请号：CN200810063052.82007 邹宏斌、贾平、祝华健、章国林、俞永平，取代哌嗪乙基磺酰胺类衍生物及制备和用途，专利号：200710156909.6李扬眉、孙 静、理查德•霍顿、俞永平，用可挥发氨烷基硅胶合成羟基多肽库的固相合成方法，公开日：2007.09.26，公开号：CN 200710066802章国林 俞永平 9α－溴－11β－羟基孕甾－1416－三烯－320－二酮合成法 公开日：2007.07.27申请号: CN200610052956.1 奖励荣誉:入选教育部“新世纪优秀人才”（2005年），浙江省“新世纪151人才工程”第一层次培养计划（2011年）。现任中印尼生物技术联合实验室中方负责人，美国Torrey Pines Institute for Molecular Studies兼职研究员、中国药学会药物化学专业委员会委员、浙江省药学会药物化学与抗生素专业委员会副主任委员，《中国现代应用药学》、《中国药物化学杂志》编委，美国化学会、美国多肽学会、中国药学会、浙江省药学会会员。